Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Ancestry Launches NGS Tests With Family History Component

    Aug 4, 2020, 07:50 AM by Michael Croft

    Bio-IT World | Ancestry has launched AncestryHealth powered by Next Generation Sequencing. It is an upgrade to AncestryDNA + Traits, adding genetic health risk reports, a family health history tool, and other resources.

    Full story
  • Panthera’s UK oncology clinical trial sites open for studies

    Aug 3, 2020, 14:16 PM by Michael Croft
    PRESTON, UNITED KINGDOM - Aug 3, 2020 -  
    • More than 1000 International Cancer Trials Suspended Due to COVID-19 
    • Panthera working with the state of the art  Rutherford Cancer Centres across the UK  is open for clinical research activities including screening
     Over a thousand oncology clinical trials have been suspended due to Covid putting back research which is vital for patients across the world
    Full story
  • Sterling Signs Deal to Produce Potential COVID-19 Drug Candidate for Moleculin

    Aug 3, 2020, 13:46 PM by Michael Croft
    CRAMLINGTON, UNITED KINGDOM - Jul 27, 2020 - Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions has signed an agreement with Moleculin Biotech, Inc
    Full story
  • Abzena appoints Matthew LeClair as SVP and Site Head of San Diego Operations

    Aug 3, 2020, 13:44 PM by Michael Croft
    SAN DIEGO, CA, UNITED KINGDOM - Aug 3, 2020 - Cambridge, UK and San Diego, CA, 3 August 2020 - Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Matthew LeClair as Senior Vice President (SVP) and Site Head of its San Diego Operations
    Full story
  • SkinCheck affordable skin cancer screening re-opens

    Aug 3, 2020, 10:11 AM by Michael Croft
    CAMBRIDGE, UK - Aug 3, 2020 - Check4Cancer, the reliable and trusted provider of early cancer detection and genetic services in the UK, is reopening its SkinHealth SkinCheck clinics following enforced closure due to COVID-19
    Full story
  • One Small Step For Open Science, One Giant Leap For Metastasis Research

    Aug 3, 2020, 08:40 AM by Michael Croft

    Bio-IT World | In a first-of-its-kind collaboration, researchers from 19 academically affiliated international laboratories have agreed to share their cell line models specific to brain metastasis with pretty much anyone who asks for them.

    Full story
  • LUMICKS enters collaboration with Glycostem to enhance NK cell-mediated immunotherapy

    Aug 3, 2020, 07:00 AM by Michael Croft
    AMSTERDAM, THE NETHERLANDS - Aug 3, 2020 - LUMICKS has entered into a collaboration with Glycostem Therapeutics, the Netherlands, to improve immunotherapeutic drug development
    Full story
  • Creative Peptides Provides Synthetic Peptides for Developing Vaccines

    Aug 3, 2020, 05:05 AM by Michael Croft
    SHIRLEY, NY - Aug 3, 2020 - In the current COVID-19 pandemic, synthetic peptides play an important role in vaccine development. Creative Peptides, a supplier mainly engaged in the production of biologically active peptides, recently announced that it can provide synthetic peptides for vaccine development
    Full story
  • Alfa Chemistry Materials—a New Option of Material Building Blocks

    Aug 1, 2020, 01:55 AM by Michael Croft
    NY, NY - Aug 1, 2020 - Material building blocks are of vital importance in various areas such as in the production of semiconductors
    Full story
  • New Data on Genetic Expression In Severe COVID-19, Pre-Existing Immune Response

    Jul 31, 2020, 08:35 AM by Michael Croft

    Bio-IT World | Research continues to uncover the underlying biology of SARS-CoV-2 and reveal some surprises. A German team found that 35% of their healthy controls had pre-existing SARS-CoV-2 cross-reactive T cells, and several groups are narrowing down the gene expression signatures that might explain why COVID-19 is so severe in some patients.

    Full story
  • Mitrefinch adds Facial Recognition to its Time and Attendance Solutions

    Jul 30, 2020, 16:58 PM by Michael Croft
    NEWTON, MA - Jul 30, 2020 - Mitrefinch delivers biometric and cloud based  time and attendance solutions for midsize and large organizations including hospitals, medical facilities and senior care centers across North and South America
    Full story
  • Spring Bank Pharmaceuticals and F-star Therapeutics Agree to Combine to Pursue Mission of Creating Next Generation Immunotherapies

    Jul 30, 2020, 12:33 PM by Michael Croft
    HOPKINTON, MA, UNITED STATES - Jul 29, 2020 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH) (“Spring Bank”), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology and inflammatory diseases, and F-star Therapeutics, Limited (“F-star”), a privately-held clinical-stage biopharmaceutical company focused on transforming the lives of patients with cancer through the development of innovative tetravalent bispecific (mAb2™) antibodies, today announced that the companies have entered into a definitive share exchange agreement pursuant to which Spring Bank will, subject to stockholder approval, acquire all of the outstanding share capital of F-star in exchange for newly issued shares of Spring Bank in an all-stock transaction
    Full story
  • Celsius Therapeutics, Twist Bioscience, And More: News From July 2020

    Jul 30, 2020, 08:50 AM by Michael Croft

    Bio-IT World July featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Celsius Therapeutics, Twist Bioscience, and more.

    Full story
  • Agendia Expands Management Team to Meet Company Momentum, Appoints Brian Dow as Chief Financial Officer

    Jul 29, 2020, 15:11 PM by Michael Croft
    IRVINE, CA - Jul 29, 2020 - Irvine, California, July 29, 2020 – Agendia, Inc., a world leader in precision oncology for breast cancer, today announced the appointment of Brian Dow as Chief Financial Officer in the continued buildout of the Company’s leadership team
    Full story
  • CareCom Joins Lyniate’s Co-Creation Lab to Address Interoperability

    Jul 29, 2020, 09:08 AM by Michael Croft
    BOSTON, MA, UNITED STATES - Jul 29, 2020 - Lyniate, a global leader in healthcare data interoperability, today announced a partnership with CareCom, a leading provider of terminology services management, to drive interoperability innovation
    Full story
  • Abzena Receives Growth Capital Investment from Newly Launched Biospring Partners

    Jul 28, 2020, 08:56 AM by Michael Croft
    CAMBRIDGE, UNITED KINGDOM - Jul 28, 2020 - Cambridge, UK, Bristol, PA and San Diego, CA -28 July 2020 - Abzena, a leading global partnership research organization providing integrated discovery, development and manufacturing of biologics and antibody drug conjugates (ADCs), has announced a $10M investment of growth capital from Biospring Partners, a New York based investment firm
    Full story
  • Zsolt Lavotha has been appointed acting CEO of Swedish Biomimetics 3000® Ltd

    Jul 28, 2020, 07:39 AM by Michael Croft
    HETHEL, NORFOLK, UNITED KINGDOM - Jul 28, 2020 - Zsolt Lavotha has been appointed acting CEO of Swedish Biomimetics 3000® Ltd (SB3000 Ltd), a pioneer in green, continuous manufacturing of pharmaceutical products
    Full story
  • Agendia Publishes Unprecedented Full Genome Dataset from MINDACT Trial for the Advancement of Translational Research in Communications Biology

    Jul 27, 2020, 10:22 AM by Michael Croft
    NEW YORK, NY, UNITED STATES - Jul 27, 2020 - Agendia, Inc., a world leader in precision oncology for breast cancer, today announced the publication of MINDACT trial data in the July 27 issue of Communications Biology, a Nature Publishers Journal
    Full story
  • Coronavirus Exposure Could Induce Long-Lasting Memory T Cells, Other COVID-19 News

    Jul 24, 2020, 08:25 AM by Michael Croft

    Bio-IT World | A new collaborative study suggests that infection and exposure to coronaviruses induces long-lasting memory T cells, which could help in the management of the current pandemic and in vaccine development against COVID-19. This, plus more, is included in this week’s COVID-19 news from the biotech and research industries.

    Full story
  • Phosplatin Therapeutics Receives Notice of US Patent Issuance for PT-112 as Therapeutic Agent for Treatment of Bone or Blood Cancers

    Jul 24, 2020, 07:58 AM by Michael Croft
    NEW YORK, NY - Jul 23, 2020 - Phosplatin Therapeutics LLC, a clinical stage pharmaceutical company focused on oncology therapeutics, today announced that the United States Patent and Trademark Office (USPTO) has issued US Patent No
    Full story
  • «
  • 201
  • 202 (current)
  • 203
  • 204
  • 205
  • 206
  • 207
  • 208
  • 209
  • 210
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy